ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,878Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 161

$1.24M Total Retail Price of All Prescriptions

Rank: 11 out of 161

569 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

6% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 5,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$157 was the average price of a prescription from this provider, compared to $221 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVETIRACETAM 509 208 1 3
NAMENDA 377 351 2 6
DONEPEZIL HCL 306 306 3 4
CARBIDOPA-LEVODOPA 305 292 4 1
ROPINIROLE HCL 246 167 5 10
TOPIRAMATE 231 74 6 5
EXELON 203 176 7 27
PHENYTOIN SODIUM EXTENDED 197 126 8 11
LEVOTHYROXINE SODIUM 163 116 9 49
CLOPIDOGREL 153 144 10 43
DIVALPROEX SODIUM 151 28 11 23
CARBAMAZEPINE 150 20 12 19
CITALOPRAM HBR 139 105 13 15
PLAVIX 136 123 14 58
OXCARBAZEPINE 131 28 15 31
WARFARIN SODIUM 129 98 16 94
LAMOTRIGINE 125 28 17 8
GABAPENTIN 121 62 18 2
TEGRETOL XR 95 34 19 63
MIRTAZAPINE 91 79 20 40
PRIMIDONE 89 59 21 9
SIMVASTATIN 82 73 22 89
SERTRALINE HCL 79 60 23 32
BACLOFEN 79 20 23 12
HYDROCODONE-ACETAMINOPHEN 77 46 S3 25 7
DILANTIN 76 58 26 18
CYMBALTA 73 42 27 16
CYCLOBENZAPRINE HCL 70 24 R 28 41
QUETIAPINE FUMARATE 70 38 28 33
DIVALPROEX SODIUM ER 69 17 30 20
TIZANIDINE HCL 68 30 31 25
POTASSIUM CHLORIDE 67 59 32 118
VIMPAT 67 36 32 14
METOPROLOL TARTRATE 67 67 32 118
LISINOPRIL 63 52 35 99
TOPAMAX 62 0 36 74
OMEPRAZOLE 62 62 36 124
BETASERON 60 11 38 66
AGGRENOX 59 58 39 57
FENTANYL 59 29 S2 39 46
CARBAMAZEPINE XR 58 0 41 79
RIVASTIGMINE 54 54 42 138
LIDODERM 54 35 42 65
AMLODIPINE BESYLATE 52 33 44 145
RISPERIDONE 50 38 45 54
VENLAFAXINE HCL 50 38 45 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.